6. Social Responsibility and Marketing of Drugs in Developing Countries: A Goal or an Oxymoron?

Chapters in this book

1. Frontmatter i
2. Contents v
3. Acknowledgments vii
4. 1.Introduction: Access to Medicines as a Human Right - What Does It Mean for Pharmaceutical Industry Responsibilities? 1
5. PART ONE. Rights, Norms, and Ethics
6. 2. Human Rights Responsibilities of Pharmaceutical Companies in Relation to Access to Medicines 25
7. 3. Improving Access to Essential Medicines: International Law and Normative Change 46
8. 4. Corporate Social Responsibility and the Right to Essential Medicines 75
9. PART TWO. Social versus Business Responsibilities
10. 5. Benchmarking and Transparency: Incentives for the Pharmaceutical Industry’s Corporate Social Responsibility 93
11. 6. Social Responsibility and Marketing of Drugs in Developing Countries: A Goal or an Oxymoron? 125
12. PART THREE. Case Studies for Achieving Corporate Responsibility
13. 7. Managing the Market for Medicines Access: Realizing the Right to Health by Facilitating Compulsory Licensing of Pharmaceuticals - A Case Study of Legislation and the Need for Reform 151
14. 8. Ubuntu, AIDS, and the King II Report: Reflections on Corporate Social Responsibility in South Africa 179
15. Annex: Human Rights Guidelines for Pharmaceutical Companies in Relation to Access to Medicines 197
16. Contributors 213